Skip to content

A Multicenter, randomized, parallel-group study assessing efficacy of actual support of renal replacement therapy modality selection program(CKD-SMD app) and home blood pressure measurement system in patients with chronic kidney disease(CKD)

A Multicenter, randomized, parallel-group study assessing efficacy of actual support of renal replacement therapy modality selection program(CKD-SMD app) and home blood pressure measurement system in patients with chronic kidney disease(CKD) - A Multicenter, randomized, parallel-group study assessing efficacy of actual support of renal replacement therapy modality selection program(CKD-SMD app) and home blood pressure measurement system in chronic kidney disease(CKD)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025792
Enrollment
68
Registered
2017-01-22
Start date
2017-03-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with chronic kidney disease(CKD)

Interventions

Intervention: Subjects receive usual care from the attending physician and we lend them the tablet equipped with CKD-SMD app and they are gotten browse by self during 8 weeks.(From the time of the sta
Lets study CKD&quot
and &quot
What is RRT?&quot
On the other hand, the advanced levels included 4 menus: &quot
Learn and consent CKD&quot
&quot
The reality of hemodialysis&quot
The reality of peritoneal dialysis&quot
The reality of kidney transplantation&quot
.In addition, we lend procedure of blood pressure measurement method and sphygmomanometer with communication function for subjects,they use it to get the data of blood pressure measurement for 8 weeks

Sponsors

Department of Sophia University
Lead Sponsor
Toranomon Hospital Kajigaya, Department of Internal Medicine, Hospital Kidney Center.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The inclusion criteria are patients in the kidney internal medicine hospital and to be assure by doctor. Patients before renal replacement therapy selection and eGFR<60. To participate in this study received sufficient information, obtained the written consent by the free will of the individual.

Exclusion criteria

Exclusion criteria: Investigator or investigator be inappropriate as determined. After renal transplantation. they are likely to introduce renal replacement therapy within one month. Minor

Design outcomes

Primary

MeasureTime frame
*The data of blood pressure:(Changes in the data of home blood pressure)

Secondary

MeasureTime frame
*Renal function:Blood sampling data (Hb,Ht,RBC.eGFR, S-cre, BUN), Spot urine measured on one occasion (proteinuria or albuminuria) s *Self efficacy,Kidney disease burden,Knowledge level of self management in CKD,Kind of decision for renal replacement therapy

Countries

Japan

Contacts

Public ContactShiho Kosaka

Department of Sophia University Nursing

skosaka-tky@umin.ac.jp03-3950-6159

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026